C9132 – Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
HCPCS Level II code · C codes: Outpatient PPS (Hospital Outpatient)
HCPCS codeC9132
- Long description
- Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
- Short description
- Kcentra, per i.u.
- Pricing indicator
53Statute- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- October 1, 2013
- Last change
- July 1, 2021 – No change
- Termination date
- June 30, 2021
Frequently asked questions
What is HCPCS code C9132?
C9132 is a HCPCS Level II code for prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity. It was discontinued on June 30, 2021.
Does Medicare cover C9132?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby C codes
- C9095 – Inj, tebentafusp-tebn, 1 mcg
- C9096 – Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
- C9097 – Inj, faricimab-svoa, 0.1 mg
- C9098 – Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- C9101 – Injection, oliceridine, 0.1 mg
- C9113 – Injection, pantoprazole sodium, per vial
- C9121 – Injection, argatroban, per 5 mg
- C9122 – Mometasone furoate sinus implant, 10 micrograms (sinuva)
- C9133 – Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.
- C9134 – Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
- C9135 – Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.
- C9136 – Injection, factor viii, fc fusion protein, (recombinant), per i.u.
- C9137 – Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.
- C9138 – Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.
- C9139 – Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.
- C9140 – Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.